News in brief

BioMérieux to take control of Japanese joint venture

©iStock

Sysmex and bioMérieux are to dissolve their joint venture in Japan.

Sysmex bioMérieux Co was formed in 2008 to bring together bioMérieux’s business and Sysmex’ expertise of the Japanese market.

It involved the manufacture and sale of in vitro diagnostic reagents and medical instruments related to microbes, genes and immunochemistry.

The company promoted and commercialized the whole bioMérieux product range in the country.

BioMérieux had been operating in the Japanese clinical diagnostics and industrial testing market through bioMérieux Japan, a fully-owned subsidiary.

Sysmex will transfer all of its holdings in Sysmex bioMérieux (34% of shares) to bioMérieux.

The distribution agreement relating to bioMérieux products in Japan between Sysmex and Sysmex bioMérieux will also terminate at the end of October.

Sysmex will continue to provide customer service for bioMérieux products until the end of March next year.

BioMérieux will then build its commercial structure to take over activities previously led by Sysmex.

Sysmex has subsidiaries in North America, Latin America, Europe, the Middle East, Africa, China and Asia Pacific and employs about 8,000 people.

BioMérieux is in more than 150 countries through 42 subsidiaries and a network of distributors. In 2016, revenues reached €2.1bn, with more than 90% of international sales.

Related News

The NucliSENS easyMAG system. Picture: bioMerieux

BioMerieux issues recall due to potential inaccurate test results

bioMérieux Tempo

USDA feels the Tempo for food safety testing

Picture: bioMérieux

BioMérieux launches automated system for DNA and RNA extraction

bioMérieux GENE-UP molecular biology platform. Picture copyright: Christian Ganet

GENE-UP system simplifies lab workflow - bioMérieux

BioMérieux acquires molecular virology lab

BioMérieux seals deal for foodborne virus detection specialist

Picture: bioMerieux headquarters in Marcy l’Etoile, France. Copyright: Christian Ganet

BioMérieux seals acquisition to boost bioinformatics offering

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.